ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	45.92	20.1	23.14	27.62	54.11
Short-Term Investments	-	-	-	9.87	-
Cash & Short-Term Investments	45.92	20.1	23.14	37.49	54.11
Cash Growth	128.43%	-13.12%	-38.27%	-30.72%	169.21%
Accounts Receivable	6.55	4.71	3.21	2.67	2.34
Inventory	8.36	6.86	7.91	9.3	4.94
Other Current Assets	2.77	1.68	1.91	1.72	0.51
Total Current Assets	63.6	33.36	36.17	51.18	61.89
Net Property, Plant & Equipment	11.05	5.09	4.95	2.7	2.78
Other Intangible Assets	13.92	-	-	-	-
Goodwill	7.47	-	-	-	-
Other Long-Term Assets	1.7	0.74	1.54	1.61	0.91
Total Assets	97.75	39.19	42.66	55.49	65.58
Accounts Payable	1.26	1.34	0.39	0.27	0.43
Accrued Expenses	7.15	6.34	4	4.89	3.14
Current Portion of Leases	0.69	0.56	0.42	0.56	0.51
Unearned Revenue	1.67	2.12	2.61	1.07	0.68
Total Current Liabilities	10.77	10.35	7.43	6.79	4.75
Long-Term Debt	49.08	-	9.95	9.89	9.84
Long-Term Leases	8.46	3.01	3.57	1.53	1.94
Other Long-Term Liabilities	0.94	0.44	0.54	0.39	0.26
Total Long-Term Liabilities	58.47	3.45	14.06	11.82	12.04
Total Liabilities	69.73	13.8	21.49	18.6	16.79
Common Stock	0.29	0.28	0.25	0.25	0.24
Additional Paid-in Capital	244.64	216.48	193.38	187.01	182.48
Retained Earnings	-216.91	-191.37	-172.46	-150.37	-133.93
Shareholders' Equity	28.02	25.39	21.17	36.89	48.79
Total Liabilities & Equity	97.75	39.19	42.66	55.49	65.58
Total Debt	58.23	3.57	13.94	11.99	12.28
Net Cash (Debt)	-12.31	16.54	9.2	25.5	41.83
Net Cash Growth	-	79.76%	-63.93%	-39.02%	-
Net Cash Per Share	-0.43	0.61	0.37	1.05	2.02
Book Value	28.02	25.39	21.17	36.89	48.79
Book Value Per Share	0.99	0.94	0.86	1.53	2.35
Tangible Book Value	6.63	25.39	21.17	36.89	48.79
Tangible Book Value Per Share	0.23	0.94	0.86	1.53	2.35

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q